Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial focus is on delivering localized therapy in ophthalmologic diseases, including diabetic macular edema and age-related neurologic conditions.
ANIRVAN GHOSH, PH.D.
Chief Executive Officer
LYNNE SULLIVAN
Chief Financial Officer and Head of Corporate Development
ALEX NGUYEN
General Counsel
PRZEMYSLAW (MIKE) SAPIEHA, PH.D.
Chief Scientist
SHARON KLIER, M.D., MPH
Senior Medical Officer
NATHAN GUZ, PH.D.
Vice President of Operations
JAMIE DANANBERG, M.D.
Senior Clinical Advisor
ROBERT B. BHISITKUL, M.D., PH.D.
Senior Clinical Advisor
Anacor Pharmaceuticals, Inc.
MICHAEL SAMAR
Chief Financial Officer,
Windgap Medical, Inc.
NATHANIEL DAVID, PH.D.
Co-Founder,
UNITY Biotechnology
ANIRVAN GHOSH, PH.D.
Chief Executive Officer,
UNITY Biotechnology
KEITH R. LEONARD JR.
Chairman,
UNITY Biotechnology
GILMORE O’NEILL, M.B.
President and Chief Executive Officer,
Editas Medicine
MARGO ROBERTS, PH.D.
Former Chief Scientific Officer,
Lyell Immunopharma, Inc.
CAMILLE SAMUELS
Partner,
Venrock
Study Design and Execution
Strategy